David M. King

3.8k total citations · 1 hit paper
45 papers, 3.0k citations indexed

About

David M. King is a scholar working on Inorganic Chemistry, Materials Chemistry and Organic Chemistry. According to data from OpenAlex, David M. King has authored 45 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Inorganic Chemistry, 10 papers in Materials Chemistry and 9 papers in Organic Chemistry. Recurrent topics in David M. King's work include Radioactive element chemistry and processing (12 papers), Coordination Chemistry and Organometallics (8 papers) and Lanthanide and Transition Metal Complexes (8 papers). David M. King is often cited by papers focused on Radioactive element chemistry and processing (12 papers), Coordination Chemistry and Organometallics (8 papers) and Lanthanide and Transition Metal Complexes (8 papers). David M. King collaborates with scholars based in United Kingdom, United States and Canada. David M. King's co-authors include Stephen T. Liddle, William Lewis, Floriana Tuna, Eric J. L. McInnes, Jonathan McMaster, Alexander J. Blake, M H St Clair, Paul Kellam, Brendan Larder and Sharon D. Kemp and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

David M. King

45 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase

1991 587 citations David M. King et al. profile →

Peers

Countries citing papers authored by David M. King

Since Specialization

Citations

This map shows the geographic impact of David M. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. King more than expected).

Fields of papers citing papers by David M. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. King. The network helps show where David M. King may publish in the future.

Co-authorship network of co-authors of David M. King

This figure shows the co-authorship network connecting the top 25 collaborators of David M. King. A scholar is included among the top collaborators of David M. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. King. David M. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reactivity of a triamidoamine terminal uranium(vi)-nitride with 3d-transition metal metallocenes 2024 ·Chemical Communications ·John A. Seed, Peter A. Cleaves, (unknown), David M. King, Floriana Tuna, Ashley J. Wooles, Nicholas F. Chilton, Stephen T. Liddle	1
2	Neptunium and plutonium complexes with a sterically encumbered triamidoamine (TREN) scaffold 2016 ·Chemical Communications ·Jessie L. Brown, Andrew J. Gaunt, David M. King, Stephen T. Liddle, Sean D. Reilly, Brian L. Scott, Ashley J. Wooles	25
3	Uranium–halide and –azide derivatives of the sterically demanding triamidoamine ligand TrenTPS [TrenTPS= {N(CH2CH2NSiPh3)3}3−] 2016 ·Polyhedron ·(unknown), (unknown), David M. King, William Lewis, Stephen T. Liddle	9
4	Two‐Electron Reductive Carbonylation of Terminal Uranium(V) and Uranium(VI) Nitrides to Cyanate by Carbon Monoxide 2014 ·Angewandte Chemie ·Peter A. Cleaves, David M. King, Christos E. Kefalidis, Laurent Maron, Floriana Tuna, Eric J. L. McInnes, Jonathan McMaster, William Lewis, Alexander J. Blake, Stephen T. Liddle	22
5	Two‐Electron Reductive Carbonylation of Terminal Uranium(V) and Uranium(VI) Nitrides to Cyanate by Carbon Monoxide 2014 ·Angewandte Chemie International Edition ·Peter A. Cleaves, David M. King, Christos E. Kefalidis, Laurent Maron, Floriana Tuna, Eric J. L. McInnes, Jonathan McMaster, William Lewis, Alexander J. Blake, Stephen T. Liddle	94
6	Single‐Molecule Magnetism in a Single‐Ion Triamidoamine Uranium(V) Terminal Mono‐Oxo Complex 2013 ·Angewandte Chemie International Edition ·David M. King, Floriana Tuna, Jonathan McMaster, William Lewis, Alexander J. Blake, Eric J. L. McInnes, Stephen T. Liddle	131
7	Isolation and characterization of a uranium(VI)–nitride triple bond 2013 ·Nature Chemistry ·David M. King, Floriana Tuna, Eric J. L. McInnes, Jonathan McMaster, William Lewis, Alexander J. Blake, Stephen T. Liddle	254
8	2-Trimethylsilylamidopyridine complexes of uranium(IV) 2011 ·Inorganica Chimica Acta ·David M. King, William Lewis, Stephen T. Liddle	12
9	Significance of tumour calcification in ovarian carcinoma 2009 ·British Journal of Radiology ·G. Burkill, Sean D. Allen, Roger A’Hern, M. Gore, David M. King	32
10	Imaging of metastatic melanoma 2006 ·Cancer Imaging ·David M. King	28
11	The radiology of gastrointestinal stromal tumours (GIST) 2005 ·Cancer Imaging ·David M. King	50
12	Phase II trial of weekly paclitaxel in patients with advanced melanoma 2005 ·Melanoma Research ·Leslie G. Walker, Heidi Schalch, David M. King, Leah L. Dietrich, (unknown), Minjung Kwak, KyungMann Kim, Mark R. Albertini	27
13	Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma 2005 ·Cancer Immunology Immunotherapy ·(unknown), Paul M. Sondel, Jacquelyn A. Hank, Paul Schalch, Jacek Gan, David M. King, Kari Kendra, (unknown), (unknown), KyungMann Kim, Mark R. Albertini	20
14	A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma 2002 ·European Journal of Surgical Oncology ·Su-Ming Tan, Kasim A. Behranwala, P. A. Trott, (unknown), E. Moskovic, Gina Brown, David M. King, Nigel Sacks, Gerald Gui	24
15	In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients 2001 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Mark R. Albertini, David M. King, Michael A. Newton, Pamela M. Vacek	8
16	Benign metastasizing leiomyoma with intracaval leiomyomatosis. 2000 ·British Journal of Radiology ·Dow‐Mu Koh, Paul Burn, David M. King	46
17	Ultrasound diagnosis of metastatic melanoma of the gallbladder. 1997 ·British Journal of Radiology ·(unknown), David M. King	24
18	Imaging of small cell carcinoma of the male urogenital tract 1996 ·Clinical Radiology ·Dominic Blunt, (unknown), David M. King	9
19	Computed tomography, diagnosis, staging and follow-up of pure granulosa cell tumour of the ovary 1994 ·Clinical Radiology ·J.E. MacSweeney, David M. King	14
20	Thiazides XIII: Dissolution testing: A bioavailability predictor for benzthiazide tablets 1982 ·Biopharmaceutics & Drug Disposition ·Vinod P. Shah, (unknown), David M. King, Vadlamani K. Prasad, Bernard E. Cabana	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact